Cargando…

Enantioselective (8+3) Cycloadditions by Activation of Donor–Acceptor Cyclopropanes Employing Chiral Brønsted Base Catalysis

A novel enantioselective (8+3) cycloaddition between donor–acceptor cyclopropanes and heptafulvenoids catalysed by a chiral bifunctional Brønsted base is described. Importantly, the reaction, which leverages an anionic activation strategy, is divergent from prototypical Lewis‐acid activation protoco...

Descripción completa

Detalles Bibliográficos
Autores principales: McLeod, David A., Thøgersen, Mathias Kirk, Barløse, Casper Larsen, Skipper, Mette Louise, Obregón, Erlaitz Basabe, Jørgensen, Karl Anker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401081/
https://www.ncbi.nlm.nih.gov/pubmed/35580010
http://dx.doi.org/10.1002/anie.202206096
_version_ 1784772890984448000
author McLeod, David A.
Thøgersen, Mathias Kirk
Barløse, Casper Larsen
Skipper, Mette Louise
Obregón, Erlaitz Basabe
Jørgensen, Karl Anker
author_facet McLeod, David A.
Thøgersen, Mathias Kirk
Barløse, Casper Larsen
Skipper, Mette Louise
Obregón, Erlaitz Basabe
Jørgensen, Karl Anker
author_sort McLeod, David A.
collection PubMed
description A novel enantioselective (8+3) cycloaddition between donor–acceptor cyclopropanes and heptafulvenoids catalysed by a chiral bifunctional Brønsted base is described. Importantly, the reaction, which leverages an anionic activation strategy, is divergent from prototypical Lewis‐acid activation protocols. A series of cyclopropylketones react with tropones affording the desired (8+3) cycloadducts in high yield and enantiomeric excess. For barbiturate substituted heptafulvenes, the (8+3) cycloaddition with cyclopropylketones proceeds in good yield, excellent diastereoselectivity and high enantiomeric excess. The experimental work is supported by DFT calculations, which indicate that the bifunctional organocatalyst activates both the donor–acceptor cyclopropane and tropone; the reaction proceeds in a step‐wise manner with the ring‐closure being the stereodetermining step.
format Online
Article
Text
id pubmed-9401081
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-94010812022-08-26 Enantioselective (8+3) Cycloadditions by Activation of Donor–Acceptor Cyclopropanes Employing Chiral Brønsted Base Catalysis McLeod, David A. Thøgersen, Mathias Kirk Barløse, Casper Larsen Skipper, Mette Louise Obregón, Erlaitz Basabe Jørgensen, Karl Anker Angew Chem Int Ed Engl Research Articles A novel enantioselective (8+3) cycloaddition between donor–acceptor cyclopropanes and heptafulvenoids catalysed by a chiral bifunctional Brønsted base is described. Importantly, the reaction, which leverages an anionic activation strategy, is divergent from prototypical Lewis‐acid activation protocols. A series of cyclopropylketones react with tropones affording the desired (8+3) cycloadducts in high yield and enantiomeric excess. For barbiturate substituted heptafulvenes, the (8+3) cycloaddition with cyclopropylketones proceeds in good yield, excellent diastereoselectivity and high enantiomeric excess. The experimental work is supported by DFT calculations, which indicate that the bifunctional organocatalyst activates both the donor–acceptor cyclopropane and tropone; the reaction proceeds in a step‐wise manner with the ring‐closure being the stereodetermining step. John Wiley and Sons Inc. 2022-05-31 2022-07-18 /pmc/articles/PMC9401081/ /pubmed/35580010 http://dx.doi.org/10.1002/anie.202206096 Text en © 2022 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
McLeod, David A.
Thøgersen, Mathias Kirk
Barløse, Casper Larsen
Skipper, Mette Louise
Obregón, Erlaitz Basabe
Jørgensen, Karl Anker
Enantioselective (8+3) Cycloadditions by Activation of Donor–Acceptor Cyclopropanes Employing Chiral Brønsted Base Catalysis
title Enantioselective (8+3) Cycloadditions by Activation of Donor–Acceptor Cyclopropanes Employing Chiral Brønsted Base Catalysis
title_full Enantioselective (8+3) Cycloadditions by Activation of Donor–Acceptor Cyclopropanes Employing Chiral Brønsted Base Catalysis
title_fullStr Enantioselective (8+3) Cycloadditions by Activation of Donor–Acceptor Cyclopropanes Employing Chiral Brønsted Base Catalysis
title_full_unstemmed Enantioselective (8+3) Cycloadditions by Activation of Donor–Acceptor Cyclopropanes Employing Chiral Brønsted Base Catalysis
title_short Enantioselective (8+3) Cycloadditions by Activation of Donor–Acceptor Cyclopropanes Employing Chiral Brønsted Base Catalysis
title_sort enantioselective (8+3) cycloadditions by activation of donor–acceptor cyclopropanes employing chiral brønsted base catalysis
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401081/
https://www.ncbi.nlm.nih.gov/pubmed/35580010
http://dx.doi.org/10.1002/anie.202206096
work_keys_str_mv AT mcleoddavida enantioselective83cycloadditionsbyactivationofdonoracceptorcyclopropanesemployingchiralbrønstedbasecatalysis
AT thøgersenmathiaskirk enantioselective83cycloadditionsbyactivationofdonoracceptorcyclopropanesemployingchiralbrønstedbasecatalysis
AT barløsecasperlarsen enantioselective83cycloadditionsbyactivationofdonoracceptorcyclopropanesemployingchiralbrønstedbasecatalysis
AT skippermettelouise enantioselective83cycloadditionsbyactivationofdonoracceptorcyclopropanesemployingchiralbrønstedbasecatalysis
AT obregonerlaitzbasabe enantioselective83cycloadditionsbyactivationofdonoracceptorcyclopropanesemployingchiralbrønstedbasecatalysis
AT jørgensenkarlanker enantioselective83cycloadditionsbyactivationofdonoracceptorcyclopropanesemployingchiralbrønstedbasecatalysis